ANN ARBOR, MI (March 31, 2025) – Arboretum Ventures, a leading healthcare venture capital firm based in Ann Arbor, Michigan, is excited to welcome Jeff Terrell as an investment Partner. Jeff joins Arboretum after 13 years with Hatteras Venture Partners in Durham, N.C. where he co-led the firm’s medical device investing practice. Jeff’s venture experience spans portfolio company operating roles, fund operations, dealmaking, and managing portfolio investments through exit. He is broadly known across the venture ecosystem and has cultivated an expansive network of trusted co-investors and corporate partners. “I am honored to join a team I’ve worked alongside for years and long admired,” Jeff commented. “I look forward to contributing to the strong foundation Arboretum has established, partnering with entrepreneurs and building innovative healthcare companies.”
Jeff has served as a board director for multiple companies including AtaCor Medical, Boomerang Medical, Cardiosense, Endogenex, and 410 Medical. Jeff was also a co-investor and director with Arboretum’s Dan Kidle at Dropworks prior to its acquisition by Bio-Rad Laboratories. He began his career at Medtronic as a clinical specialist and sales representative focused on spinal implants and image-guided surgical tools. Prior to joining Medtronic, Jeff realized a childhood ambition to become a professional quarterback and spent time in training camp with the Kansas City Chiefs and Dallas Cowboys.
With Jeff joining the partnership, Arboretum will bolster its successful team of experienced healthcare investors who have built a portfolio of transformational companies. Arboretum’s notable successes include Accuri Cytometers, Inogen, NxThera, NeuMoDx Molecular, nVision, Rethink, Dropworks, and BioIQ. “Jeff will add tremendous depth and reach to our investment team,” noted Managing Partner Tom Shehab, MD. “Beyond his expertise and reputation as a talented investor, Jeff brings an energy and enthusiasm that will be tremendously additive to our culture.”
Jeff earned his undergraduate degree from Princeton University and an MBA at Duke University’s Fuqua School of Business, with a focus on healthcare and finance. Jeff previously served on the Oversight Committee for the National Football League’s Head Health Tech Challenge and as a director on both the Council for Entrepreneurial Development in Durham and the Durham Chamber of Commerce.
About Arboretum Ventures:
Arboretum Ventures is a venture capital firm specializing in the healthcare sector. Founded in 2002, the firm has raised $1 billion in capital across its funds with its most recent Fund VI closing in 2023 at $268 million. Arboretum focuses on capital‐efficient investment opportunities in medical devices, life science tools & diagnostics, tech‐enabled care delivery, and pharma adjacencies. Arboretum’s guiding vision is to identify transformative healthcare companies developing novel solutions to significant healthcare issues that simultaneously reduce cost and improve outcomes. For information, visit www.arboretumvc.com.